Drugs / Inactivated Hepatitis A Vaccine, Lu8 Strain
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02601040 | Nov 2011 → Jun 2014 | hepatitis A virus infection | Jiangsu Province Centers for Disease Control and Prevention | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated Hepatitis A Vaccine, Lu8 Strain | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02601040 ↗ |
| Known as | HA-I | “9000 participants were enrolled in the phase IV study of live attenuated HA (HA-L) or inactivated HA (HA-I) vaccines.” PMID 34222044 ↗ Jun 2021 |
| Modality | Vaccine | “Inactivated and Live Attenuated Hepatitis A Vaccines” NCT02601040 ↗ |
| Route | Intramuscular | “Health subjects received inactivated Hepatitis A vaccine intramuscularly in the deltoid region.” NCT02601040 ↗ |